Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RICHARD P VU

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1316930241
CMS profile
241560
Location
COLORADO SPRINGS, CO

General Payments · PY2018–2024

$2,322.57

  • Reported across 142 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$257.23

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $257.23 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $39.58 2
Amgen Inc. $37.19 2
Acerta Pharma LLC $33.99 2
Electromed, Inc. $31.70 2
Edwards Lifesciences Corporation $27.78 1
Lilly USA, LLC $24.47 1
Hologic Sales and Service, LLC $22.35 1
IRONSHORE PHARMACEUTICALS INC. $22.23 1
ABBVIE INC. $17.94 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $233.53 16
PY2019 $301.14 20
PY2020 $452.56 29
PY2021 $504.53 32
PY2022 $294.27 17
PY2023 $279.31 15
PY2024 $257.23 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.94 03/25/2024 Food and Beverage Undisputed 01/23/2026 1106293590 CMS
Amgen Inc. $21.73 06/21/2024 Food and Beverage Undisputed 01/23/2026 1117711250 CMS
Amgen Inc. $15.46 07/15/2024 Food and Beverage Undisputed 01/23/2026 1117711252 CMS
AstraZeneca Pharmaceuticals LP $13.79 06/04/2024 Food and Beverage Undisputed 01/23/2026 1104540078 CMS
AstraZeneca Pharmaceuticals LP $20.20 09/23/2024 Food and Beverage Undisputed 01/23/2026 1104205795 CMS
Edwards Lifesciences Corporation $27.78 02/19/2024 Food and Beverage Undisputed 01/23/2026 1138798906 CMS
Electromed, Inc. $24.87 10/29/2024 Food and Beverage Undisputed 01/23/2026 1137915812 CMS
Electromed, Inc. $6.83 12/10/2024 Food and Beverage Undisputed 01/23/2026 1137915814 CMS
Hologic Sales and Service, LLC $22.35 06/25/2024 Food and Beverage Undisputed 01/23/2026 1084878438 CMS
IRONSHORE PHARMACEUTICALS INC. $22.23 09/12/2024 Food and Beverage Undisputed 01/23/2026 1146309703 CMS
Lilly USA, LLC $24.47 09/10/2024 Food and Beverage Undisputed 01/23/2026 1135354314 CMS
Novo Nordisk Inc $18.23 08/27/2024 Food and Beverage Undisputed 01/23/2026 1096879122 CMS
Novo Nordisk Inc $21.35 12/10/2024 Food and Beverage Undisputed 01/23/2026 1096752643 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.